Sun Pharma Q2 Profit Falls 36% on Exceptional Charges
Sun Pharma's second-quarter profit fell 36% because of exceptional charges, even though revenue grew. Excluding those one-off items, adjusted net profit stood at ₹3,162 crore. Revenue still rose, so the drop is mainly about these charges.
Context
Context: Sun Pharma is one of India's largest drugmakers, and exceptional charges are one-off costs that companies report separately from routine operations. Quarterly results like this show investors how much of a profit drop is temporary.
Burning Potato score: 58%